New breathing therapy shows promise for Long-COVID breathlessness

NCT ID NCT06503913

Completed Symptom relief Sponsor: University of Salford Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a therapy called Cognitive Muscular Therapy (CMT) for people with Long-COVID who have trouble breathing. CMT combines breathing retraining with techniques to reduce overactive muscles that can interfere with breathing. 18 adults with moderate to severe breathlessness took part. The goal was to see if CMT could reduce breathlessness and improve overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cognitive Muscular Therapy (a type of physiotherapy that retrains breathing and reduces overactive postural muscles)
What this could lead to: If it works, this could offer a non-drug way to manage breathlessness in people with Long-COVID.
What could go wrong: This was a very small study (18 people) with no control group, so results may not apply widely. The therapy is also new and needs more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19 Respiration Disorders respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG COVID RESPIRATORY DISEASE

Contacts and locations

Locations

University of Salford

Manchester, Greater Manchester, M6 6PU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.